Lenvima cancer medication
Box containing capsules of the cancer drug lenvatinib, marketed as Lenvima. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking the action of specific enzymes involved in the growth and spread of cancer cells. Common side effects of lenvatinib may include fatigue, hypertension, diarrhoea and decreased appetite., by DR P. MARAZZI/SCIENCE PHOTO LIBRARY
Details
License type
Rights Managed